Board of Trustees

The Board of Trustees (Kuratorium) is a means to enhance outreach and exchange with the public at large. It may also provide important non-scientific guidance for the strategic development of the institute and open up for new funding possibilities. For this reason Max Planck Institute for Biology of Ageing has, in collaboration with the neighbouring MPI for Metabolism Research, compiled a list of high-level individuals representing different social stakeholder groups who will support us in our work.

  • Dr. Enno Aufderheide | General Secretary of the Alexander von Humboldt Foundation
  • Prof. Axel Freimuth (CHAIR) | Rector of University of Cologne
  • Dr. Henrike Hartmann | Volkswagen Foundation, Head of Funding
  • Prof. Heribert Hirte | Member of the German Bundestag / Parliament
  • Dr. Philip Just Larsen | Senior Vice President, Global Head of research at Bayer Pharmaceuticals
  • Dr. Helge Lubenow | Consultant at AGOS Consulting
  • Dr. Ralf Müller-Schmid | Chief Editor at DRadio Wissen
  • Frau Elfi Scho-Antwerpes | Mayor, City of Cologne (MdB)

 Members of the Scientific Advisory Board

The scientific work of the Institute is evaluated every three years by an international panel of independent experts, forming the Scientific Advisory Board (SAB). 

  • Prof. Dr. John Blenis - Weill Cornell Medicine, School of Medical Sciences, New York, USA
  • Prof. Dr. Ivan Đikić - Goethe University Medical Faculty, Institute of Biochemistry II, Frankfurt Am Main, Germany
  • Prof. Dr. Vera Gorbunova - University of Rochester, Department of Biology, River Campus, Rochester, USA
  • Prof. Dr. Michael N. Hall - University of Basel, Biozentrum, Basel, Switzerland
  • Prof. Dr. Heidi Mcbride - McGill University, The Neuro (Montreal Neurological Institute-Hospital), Montreal, Canada
  • Prof. Dr. Laura Niedernhofer - University of Minnesota, College of Biological Science, Minneapolis, USA
  • Prof. Dr. Ellen Nollen - University of Groningen, Faculty of Medical Sciences, Groningen, The Netherlands
  • Prof. Dr. Thomas Rando - CHAIR - Stanford University School of Medicine, Department of Neurology and Neurological Sciences, Stanford, USA
  • Prof. Dr. Wolf Reik - Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom
  • Prof. Dr. Eric Shoubridge - McGill University/MNI, Department of Molecular Neurogenetics, Montreal, Canada
  • Prof. Dr. Marian Walhout - University of Massachusetts Medical School, Albert Sherman Center, Worcester, USA
  • Prof. Dr. Tony Wyss-Coray - Stanford University, Department of Neurology, Stanford, USA
Go to Editor View